Touted as a major victory in the battle against breast cancer, researchers in the United States have announced a new class of chemotherapy drug.
Scientists describe it as an "armed antibody", TDM1 is a "magic bullet" treatment, killing cancer cells without destroying the patients' quality of life.
Al Jazeera's Anand Naidoo reports from Washington.
